Abstract

Synthetic acyclic receptors, composed of two arms connected with a spacer enabling molecular recognition, have been intensively explored in host-guest chemistry in the past decades. They fall into the categories of molecular tweezers, clefts and clips, depending on the geometry allowing the recognition of various guests. The advances in synthesis and mechanistic studies have pushed them forward to pharmaceutical applications, such as neurodegenerative disorders, infectious diseases, cancer, cardiovascular disease, diabetes, etc. In this review, we provide a summary of the synthetic molecular tweezers, clefts and clips that have been reported for pharmaceutical applications. Their structures, mechanism of action as well as in vitro and in vivo results are described. Such receptors were found to selectively bind biological guests, namely, nucleic acids, sugars, amino acids and proteins enabling their use as biosensors or therapeutics. Particularly interesting are dynamic molecular tweezers which are capable of controlled motion in response to an external stimulus. They proved their utility as imaging agents or in the design of controlled release systems. Despite some issues, such as stability, cytotoxicity or biocompatibility that still need to be addressed, it is obvious that molecular tweezers, clefts and clips are promising candidates for several incurable diseases as therapeutic agents, diagnostic or delivery tools.

Highlights

  • Introduction to MolecularTweezers, Clefts and ClipsHost-guest chemistry has experienced tremendous development in the past decades

  • This review is aimed at collecting the pharmaceutical applications of molecular tweezers, clefts, and clips, using a comprehensive approach to relate some structural features to their pharmaceutical application

  • Starting from simple synthetic receptors, supramolecular systems have grown in complexity and control leading to molecular motors and nanomachines, recently rewarded by the Nobel Price of Chemistry awarded to Stoddard, Sauvage and Feringa [106]

Read more

Summary

Nucleic

Nature has has developed developed complex complex systems systems to to recognize recognize selectively selectively biological biological guests, guests, such such as as DNA. Interfering with this process enable a pharmaceutical control over gene expression and or proteins. (e.g., doxorubicin, doxorubicin,mitoxantrone), mitoxantrone), groove binding (e.g., netropsin), cross-linking (e.g., alkylation of bases (e.g., chlorambucil) or by inducing cleavage (e.g., etoposide, bleomycins). Molecular tweezers have been pharmaceutical tool to interact with Their selectivity has been exploited to recognize specific developed as a pharmaceutical tool to interact with DNA. Their selectivity has been exploited to sequencesspecific of DNA,sequences in order to correct.

Purine
Examples
DNA Binding and Anticancer Agents
ExamplesTweezers of molecular tweezers based on
Enzyme Inhibition
Phosphate
Prevention of Protein Aggregation In Amyloidosis
Inhibition of Enveloped Viruses
Sugar Recognition
Stimuli-Responsive Tweezers for Drug Delivery
Lipid Switches for Controlled Drug Release
Summary and Outlook
In Which Disease Could Molecular Tweezers be Used?
Findings
Towards New Molecular Tweezers?

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.